Overall Technical outlook

Price Summary

Concord Biotech Limited's stock opened at 1655.3 on 2025-05-29, surged to a high of 1688.8, hit a low of 1638.1, and closed up 0.7% at 1666.9, with 237686 shares traded.
The stock reached its highest price of 2601.1 and lowest price of 1386.7 over the last 52 weeks.
5 analysts predict that the future price of CONCORDBIO will be in the range of 1620.0 to 2187.0, with a mean expected price of about 1906.8.

Technicals

Support and Resistance: The current price of 1666.9 is supported at 1511.1, with resistance at 1747.45. This suggests that the price for CONCORDBIO might remain between these levels, where 1511.1 acts as a floor and 1747.45 as a ceiling in the market.
CONCORDBIO supportResistance 7a1a45
Support/Resistance for CONCORDBIO


Aroon: Aroon's bullish trend persists, with Aroon Up staying at the 100 level. This indicates strong market momentum, but further analysis using additional indicators is necessary to determine the trend's sustainability and future direction.
CONCORDBIO aroon 7a1a45
Aroon chart for Concord Biotech Limited


Bol. Bands: The current price for CONCORDBIO remains above the upper Bollinger Band, having stayed there since its recent upward move. This situation suggests that the asset is in a strong bullish phase, possibly overbought. While this could indicate continued momentum, traders should be cautious as prolonged periods above the band often lead to corrections or reversals, signaling a potential change in trend.
CONCORDBIO bbands 7a1a45
Bolinger Bands chart for Concord Biotech Limited


Parabolic SAR: The PSAR remains bullish, setting a critical support level that may help sustain the market's upward trend. This persistent bullish outlook suggests that the market is likely to continue climbing, with the support level offering a foundation for further growth.
CONCORDBIO psar 7a1a45
Parabolic Stop and Reverse chart for Concord Biotech Limited


Stochastic: The stochastic indicator shows a bullish sentiment, with the K-line above both the D-line and the 80 level. This configuration indicates strong upward momentum, suggesting that CONCORDBIO may continue its upward trend. Traders might view this as a sign of sustained strength.
CONCORDBIO stoch 7a1a45
Stochastic chart for Concord Biotech Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
CONCORDBIO trippleSMA 7a1a45
Tripple SMA chart for Concord Biotech Limited


Before focusing on technical indicators like stock price and volume, it's important to consider a company's fundamentals. These include financial metrics such as profitability, revenue growth, and debt levels. Furthermore, understanding the industry landscape, including competition and consumer trends, provides essential context. By combining this fundamental analysis with technical data, investors can make more informed decisions and draw deeper conclusions about the company's potential for future growth and success.